ICH E14: A New Regulatory Guidance on the Clinical Evaluation of QT/QTc Internal Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs

MLA

Sager, Philip T., et al. “ICH E14: A New Regulatory Guidance on the Clinical Evaluation of QT/QTc Internal Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs.” Therapeutic Innovation and Regulatory Science, vol. 39, no. 4, Oct. 2005, pp. 387–94. EBSCOhost, https://doi.org/10.1177/009286150503900407.

APA

Sager, P. T., Nebout, T., & Darpo, B. (2005). ICH E14: A New Regulatory Guidance on the Clinical Evaluation of QT/QTc Internal Prolongation and Proarrhythmic Potential for Non-antiarrhythmic Drugs. Therapeutic Innovation and Regulatory Science, 39(4), 387–394. https://doi.org/10.1177/009286150503900407

Chicago

Sager, Philip T., Thierry Nebout, and Borje Darpo. 2005. “ICH E14: A New Regulatory Guidance on the Clinical Evaluation of QT/QTc Internal Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs.” Therapeutic Innovation and Regulatory Science 39 (4): 387–94. doi:10.1177/009286150503900407.